RAN and ovarian cancer: Moreover, RAN and HSBP1, when knocked down in ovarian cancer cells with high Lin28A expression, resulted in reduced malignancy characteristics, such as cell survival, invasion, and tumor growth in vivo, alongside increased apoptosis rates.